BlackBarn Capital Partners LP
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 2010204
NEW YORK, NY
Position in AMRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,503,000
+$1,993,500 QoQ
Shares Held
1,300,000
-21.2% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
5.60%
of 13F equity value
Holder Rank
#22
of 311 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BlackBarn Capital Partners LP holds $22,503,000 across 1 Drug Manufacturers - Specialty & Generic name. AMRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
1,300,000 | $22,503,000 |
All Filings in AMRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,503,000 | 1,300,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,509,500 | 1,650,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,782,000 | 1,570,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,916,414 | 2,189,452 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,882,751 | 3,446,570 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,148,260 | 2,881,654 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,572,000 | 2,850,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,064,611 | 2,411,612 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,700,000 | 2,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,564,579 | 1,413,297 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||